Cargando…
The renal effects of N10-propargyl-5,8-dideazafolic acid (CB3717) and a non-nephrotoxic analogue ICI D1694, in mice.
N-(5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)- N-methylamino]-2-thenoyl)-L-glutamic acid (ICI D1694) is an analogue of the thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid (CB3717). CB3717 was found to be active in early clinical studies, but its use was limited by nep...
Autores principales: | Jodrell, D. I., Newell, D. R., Morgan, S. E., Clinton, S., Bensted, J. P., Hughes, L. R., Calvert, A. H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977485/ https://www.ncbi.nlm.nih.gov/pubmed/1931603 |
Ejemplares similares
-
Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancer.
por: Harding, M. J., et al.
Publicado: (1988) -
The efficacy of 5-fluorouracil in human colorectal cancer is not enhanced by thymidylate synthetase inhibition with CB3717 (N10-propargyl-5,8 dideazafolic acid).
por: Cantwell, B. M., et al.
Publicado: (1988) -
Pharmacokinetic studies with the antifolate C2-desamino-C2-methyl-N10-propargyl-2'-trifluoromethyl-5,8-dideazafolic acid (CB3988) in mice and rats using in vivo 19F-NMR spectroscopy.
por: Newell, D. R., et al.
Publicado: (1990) -
Moderate antiproliferative effect of the antifolate CB3717 in the BN myeloid leukaemia model.
por: Ermens, A. A., et al.
Publicado: (1988) -
Toxicities of the antifoliate, CV3717
Publicado: (1988)